These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11811694)

  • 1. Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies.
    Serafin IL; Aaskov JG
    Arch Virol; 2001 Dec; 146(12):2469-79. PubMed ID: 11811694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody.
    Lok SM; Ng ML; Aaskov J
    J Med Virol; 2001 Oct; 65(2):315-23. PubMed ID: 11536239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.
    Beasley DW; Aaskov JG
    Virology; 2001 Jan; 279(2):447-58. PubMed ID: 11162801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.
    Jianmin Z; Linn ML; Bulich R; Gentry MK; Aaskov JG
    Arch Virol; 1995; 140(5):899-913. PubMed ID: 7541621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
    Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
    J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
    Tang CT; Li PC; Liu IJ; Liao MY; Chiu CY; Chao DY; Wu HC
    PLoS Negl Trop Dis; 2015; 9(7):e0003903. PubMed ID: 26135599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L
    APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.
    Simantini E; Banerjee K
    Arch Virol; 1995; 140(7):1257-73. PubMed ID: 7646356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
    Lai CJ; Goncalvez AP; Men R; Wernly C; Donau O; Engle RE; Purcell RH
    J Virol; 2007 Dec; 81(23):12766-74. PubMed ID: 17881450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    Goncalvez AP; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
    Gelanew T; Hunsperger E
    Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
    Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.